AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22524633 — intervention group
Group type: COMPARATOR
Intervention: Standard group (SG)
Number of subjects: 205
Study 20402438 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intention intervention
Number of subjects: 349
Study 20402438 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 349
Study 18533780 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezo-ceramic device
Number of subjects: 59
Study 18533780 — intervention group
Group type: COMPARATOR
Intervention: Curets
Number of subjects: 59
Study 18533780 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Piezo-ceramic device and Curets)
Number of subjects: 59
Study 16128794 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-zinc toothpastes
Number of subjects: 3000
Study 12856249 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (Botox; Allergan, Ettlingen, Germany) injections into masticatory muscles
Number of subjects: 90
Study 12856249 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 90
Study 10566717 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam (7.5 mg mixed with apple juice)
Number of subjects: 99
Study 10566717 — intervention group
Group type: COMPARATOR
Intervention: Placebo (apple juice)
Number of subjects: 99
Study 8735681 — intervention group
Group type: EXPERIMENTAL
Intervention: TROPDEX (tropisetron 5 mg i.v. + dexamethasone 20 mg i.v. on day 1, followed by oral tropisetron 5 mg daily and dexamethasone 4 mg twice daily from day 2 to 6)
Number of subjects: 36
Study 8735681 — intervention group
Group type: COMPARATOR
Intervention: METDEX (metoclopramide 1 mg kg‐1 i.v. + dexamethasone 20 mg i.v. + diphenhydramine 25 mg i.v. on day 1, followed by oral metoclopramide 20 mg 6 hourly from day 2 to 6)
Number of subjects: 36
Study 8735681 — intervention group
Group type: EXPERIMENTAL
Intervention: TROPDEX (in second cycle)
Number of subjects: 36
Study 8735681 — intervention group
Group type: EXPERIMENTAL
Intervention: TROPDEX (in first cycle)
Number of subjects: 36
Study 1768543 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.7% MAC cyclopropane
Number of subjects: 6
Study 1768543 — intervention group
Group type: EXPERIMENTAL
Intervention: 8.8% MAC cyclopropane
Number of subjects: 6
Study 1768543 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.3% MAC halothane
Number of subjects: 6
Study 1768543 — intervention group
Group type: EXPERIMENTAL
Intervention: 9.3% MAC halothane
Number of subjects: 6
Study 1768543 — intervention group
Group type: COMPARATOR
Intervention: Halothane (both concentrations)
Number of subjects: 6
Study 1768543 — intervention group
Group type: COMPARATOR
Intervention: Air (control)
Number of subjects: 6
Study 6778574 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (10 to 40 microgram/min)
Number of subjects: 12
Study 6778574 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (200 and 400 micrograms/min)
Number of subjects: 12
Study 6778574 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (800 micrograms/min)
Number of subjects: 12
Study 29741443 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised training group (ITG, n = 9)
Number of subjects: 17
Study 29741443 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG, n = 8)
Number of subjects: 17
Study 26563095 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention (BI)
Number of subjects: 60
Study 26563095 — intervention group
Group type: COMPARATOR
Intervention: Business as usual (BAU)
Number of subjects: 60
Study 26563095 — intervention group
Group type: COMPARATOR
Intervention: Population controls (non-intervention)
Number of subjects: 60
Study 26563095 — intervention group
Group type: EXPERIMENTAL
Intervention: MOH patients
Number of subjects: 60
Study 24275013 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine fumarate extended release (QXR) 300 mg/day
Number of subjects: 60
Study 24275013 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (ESC) 10 mg/day
Number of subjects: 60
Study 22544892 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 83
Study 22544892 — intervention group
Group type: COMPARATOR
Intervention: Educational control programme
Number of subjects: 83
Study 19028834 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 130
Study 19028834 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 130
Study 17940752 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0
Study 17940752 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HTTLPR genotype (LL homozygosity)
Number of subjects: 0
Study 17940752 — intervention group
Group type: COMPARATOR
Intervention: Control procedures (not specified)
Number of subjects: 0
Study 15562384 — intervention group
Group type: EXPERIMENTAL
Intervention: Gliclazide
Number of subjects: 0
Study 15562384 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaglinide
Number of subjects: 0
Study 14976046 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged rituximab administration (375 mg/m(2) every 2 months for 4 times)
Number of subjects: 202
Study 14976046 — intervention group
Group type: COMPARATOR
Intervention: No further treatment after initial response or stable disease
Number of subjects: 202
Study 14976046 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged rituximab administration
Number of subjects: 202
Study 14976046 — intervention group
Group type: COMPARATOR
Intervention: No further treatment in chemotherapy-naive patients
Number of subjects: 202
Study 14976046 — intervention group
Group type: COMPARATOR
Intervention: No further treatment in patients responding to induction treatment
Number of subjects: 202
Study 10729688 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially randomized patient preference (PRPP) design
Number of subjects: 0
Study 10729688 — intervention group
Group type: COMPARATOR
Intervention: Conventional trial methods
Number of subjects: 0
Study 9481966 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine with 1/80,000 epinephrine
Number of subjects: 0
Study 9481966 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1/80,000 epinephrine + 0.5% bupivacaine
Number of subjects: 0
Study 1439632 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillamine
Number of subjects: 29
Study 1439632 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclofenil
Number of subjects: 29
Study 1439632 — intervention group
Group type: COMPARATOR
Intervention: Control (neither treatment)
Number of subjects: 29
Study 3895024 — intervention group
Group type: EXPERIMENTAL
Intervention: Methicillin (200 mg/kg divided into six i.v. doses during 24 hours starting at the induction of anesthesia)
Number of subjects: 152
Study 3895024 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antibiotics)
Number of subjects: 152
Study 3895024 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall infection rate across both groups
Number of subjects: 152
Study 3895024 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated group
Number of subjects: 152
Study 3895024 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 152
Study 31776740 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CT-guided lung biopsy
Number of subjects: 271
Study 31776740 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose CT-guided lung biopsy
Number of subjects: 271
Study 29149455 — intervention group
Group type: EXPERIMENTAL
Intervention: CMR-video (video information + standard text-information)
Number of subjects: 148
Study 29149455 — intervention group
Group type: COMPARATOR
Intervention: CMR-standard (standard text-information alone)
Number of subjects: 148
Study 29149455 — intervention group
Group type: COMPARATOR
Intervention: Myocardial perfusion scintigraphy
Number of subjects: 148
Study 27091236 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 200 or 300 U administered as needed for symptom control
Number of subjects: 227
Study 24444783 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400mg
Number of subjects: 24
Study 24444783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 22441975 — intervention group
Group type: EXPERIMENTAL
Intervention: Oversewing (group A)
Number of subjects: 120
Study 22441975 — intervention group
Group type: EXPERIMENTAL
Intervention: Buttressed transection with polyglycolide acid and trimethylene carbonate (group B)
Number of subjects: 120
Study 22441975 — intervention group
Group type: EXPERIMENTAL
Intervention: Staple-line roofing with gelatin fibrin matrix (group C)
Number of subjects: 120
Study 20100374 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic yoghurt (300 g daily for 6 weeks)
Number of subjects: 90
Study 20100374 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional yoghurt (300 g daily for 6 weeks)
Number of subjects: 90
Study 20100374 — intervention group
Group type: COMPARATOR
Intervention: Control group (no yoghurt)
Number of subjects: 90
Study 19074086 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombopoietin receptor agonists (TPO receptor agonists)
Number of subjects: 0
Study 19074086 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant TPO
Number of subjects: 0
Study 19074086 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel compounds designed to stimulate the TPO receptor
Number of subjects: 0
Study 19074086 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse effects of TPO receptor agonists
Number of subjects: 0
Study 15905767 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon Kyphoplasty
Number of subjects: 51
Study 15905767 — intervention group
Group type: COMPARATOR
Intervention: Vertebroplasty
Number of subjects: 51
Study 12571854 — intervention group
Group type: EXPERIMENTAL
Intervention: LJP 394
Number of subjects: 230
Study 12571854 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study 9558537 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid fixation with bicortical position screws
Number of subjects: 127
Study 9558537 — intervention group
Group type: COMPARATOR
Intervention: Wire fixation with inferior border wires
Number of subjects: 127
Study 7700724 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal delivery
Number of subjects: 0
Study 7700724 — intervention group
Group type: COMPARATOR
Intervention: Elective cesarean section
Number of subjects: 0
Study 2791561 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine iron supplementation
Number of subjects: 2960
Study 2791561 — intervention group
Group type: COMPARATOR
Intervention: Selective iron supplementation
Number of subjects: 2960
Study 889511 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% clonidine hydrochloride solution
Number of subjects: 21
Study 889511 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% clonidine hydrochloride solution
Number of subjects: 21
Study 889511 — intervention group
Group type: COMPARATOR
Intervention: 2% pilocarpine hydrochloride solution
Number of subjects: 21
Study 889511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 889511 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (both concentrations)
Number of subjects: 21
Study 29289382 — intervention group
Group type: EXPERIMENTAL
Intervention: Edmonston-Zagreb (EZ) strain
Number of subjects: 200
Study 29289382 — intervention group
Group type: COMPARATOR
Intervention: AIK-C strain
Number of subjects: 200
Study 26099369 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat milk (LFM)
Number of subjects: 34
Study 26099369 — intervention group
Group type: COMPARATOR
Intervention: Apple juice (AJ)
Number of subjects: 34
Study 26099369 — intervention group
Group type: COMPARATOR
Intervention: Water (W)
Number of subjects: 34
Study 25167875 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 separate injections (0.2 + 0.2 mL/kg) of contrast medium (gadoteridol) in Group A
Number of subjects: 40
Study 25167875 — intervention group
Group type: COMPARATOR
Intervention: Single injection of 0.4 mL/kg of contrast medium (gadoteridol) in Group B
Number of subjects: 40
Study 25167875 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups underwent delayed studies
Number of subjects: 40
Study 22424466 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed breasts (breast compress warmed in a microwave oven for 1 minute at 180 W applied for 20 minutes)
Number of subjects: 39
Study 22424466 — intervention group
Group type: COMPARATOR
Intervention: Nonwarmed breasts
Number of subjects: 39
Study 20398359 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular phase
Number of subjects: 38
Study 20398359 — intervention group
Group type: COMPARATOR
Intervention: Luteal phase
Number of subjects: 38
Study 18329961 — intervention group
Group type: EXPERIMENTAL
Intervention: iPods (four types) placed 2 inches anterior to the pacemaker for up to 10 seconds
Number of subjects: 100
Study 16492643 — intervention group
Group type: EXPERIMENTAL
Intervention: Child receiving chemotherapy for cancer
Number of subjects: 0
Study 16492643 — intervention group
Group type: EXPERIMENTAL
Intervention: Child with cancer in remission
Number of subjects: 0
Study 16492643 — intervention group
Group type: EXPERIMENTAL
Intervention: Physically healthy child
Number of subjects: 0
Study 16492643 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to information about cancer
Number of subjects: 0
Study 12094850 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg once daily (group 15qd)
Number of subjects: 137
Study 12094850 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg on alternate days (group 30qod)
Number of subjects: 137
Study 12094850 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens (15 mg daily and 30 mg alternate days)
Number of subjects: 137
Study 10404055 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG treatment
Number of subjects: 44
Study 10404055 — intervention group
Group type: COMPARATOR
Intervention: Non-IVIG treatment
Number of subjects: 44
Study 10404055 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 44
Study 7590046 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hyoscine 20 mg plus inhaled oxygen on demand
Number of subjects: 131
Study 7590046 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitrous oxide on demand
Number of subjects: 131
Study 7590046 — intervention group
Group type: COMPARATOR
Intervention: Sterile water injection plus inhaled oxygen on demand (placebo)
Number of subjects: 131
Study 2082315 — intervention group
Group type: COMPARATOR
Intervention: Oral ketorolac 10 mg
Number of subjects: 747
Study 2082315 — intervention group
Group type: COMPARATOR
Intervention: Oral ketorolac 12.5 mg
Number of subjects: 747
Study 2082315 — intervention group
Group type: COMPARATOR
Intervention: Oral ketorolac 100 mg
Number of subjects: 747
Study 2082315 — intervention group
Group type: COMPARATOR
Intervention: Oral ketorolac 200 mg
Number of subjects: 747
Study 2082315 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular ketorolac 90 mg
Number of subjects: 747
Study 2082315 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular ketorolac 10 mg
Number of subjects: 747
Study 2082315 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular ketorolac 30 mg
Number of subjects: 747
Study 2082315 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular ketorolac 10 mg and 30 mg
Number of subjects: 747
Study 2082315 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac doses of 2.5 and 5 mg
Number of subjects: 747
Study 2082315 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac doses of 10 mg or more
Number of subjects: 747
Study 2082315 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac doses of 90 mg or more
Number of subjects: 747
Study 476711 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-drug regimen (prednisone, cyclophosphamide, actinomycin D, vincristine, and daunorubicin)
Number of subjects: 26
Study 476711 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-drug regimen (cyclophosphamide and vincristine)
Number of subjects: 26
Study 6851562 — intervention group
Group type: EXPERIMENTAL
Intervention: 21-day low-dose combined pill
Number of subjects: 150
Study 6851562 — intervention group
Group type: EXPERIMENTAL
Intervention: 21-day low-dose combined pill followed by 7 days of iron-containing pill
Number of subjects: 150
Study 6851562 — intervention group
Group type: EXPERIMENTAL
Intervention: 63-day low-dose combined pill followed by 7 days of no pill intake
Number of subjects: 150
Study 6851562 — intervention group
Group type: COMPARATOR
Intervention: Lippes IUD
Number of subjects: 150
Study 6851562 — intervention group
Group type: COMPARATOR
Intervention: TCu 220C
Number of subjects: 150
Study 6851562 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestasert
Number of subjects: 150
Study 30632796 — intervention group
Group type: EXPERIMENTAL
Intervention: High self-efficacy (HSE)
Number of subjects: 62
Study 30632796 — intervention group
Group type: EXPERIMENTAL
Intervention: Low self-efficacy (LSE)
Number of subjects: 62
Study 30632796 — intervention group
Group type: COMPARATOR
Intervention: Neutral self-efficacy (NSE)
Number of subjects: 62
Study 28318923 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-dimensional prediction technique
Number of subjects: 30
Study 28318923 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional prediction technique
Number of subjects: 30
Study 28318923 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 30
Study 27004282 — intervention group
Group type: EXPERIMENTAL
Intervention: Fit restorations (assembled by an intraoral bonding procedure)
Number of subjects: 20
Study 27004282 — intervention group
Group type: COMPARATOR
Intervention: Misfit restorations (cast in one piece)
Number of subjects: 20
Study 27004282 — intervention group
Group type: EXPERIMENTAL
Intervention: Fit restorations
Number of subjects: 20
Study 27004282 — intervention group
Group type: COMPARATOR
Intervention: Misfit restorations
Number of subjects: 20
Study 24286591 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic training (HT)
Number of subjects: 40
Study 24286591 — intervention group
Group type: COMPARATOR
Intervention: Normoxic training (NT)
Number of subjects: 40
Study 22252613 — intervention group
Group type: EXPERIMENTAL
Intervention: Z- BEAM (Ibritumomab tiuxetan at 0.4 mCi/kg on day -14 before ASCT)
Number of subjects: 43
Study 22252613 — intervention group
Group type: COMPARATOR
Intervention: BEAM alone
Number of subjects: 43
Study 22252613 — intervention group
Group type: EXPERIMENTAL
Intervention: Z- BEAM
Number of subjects: 43
Study 19968839 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole (two doses)
Number of subjects: 0
Study 19968839 — intervention group
Group type: COMPARATOR
Intervention: Non-parasitaemic newborns (control group)
Number of subjects: 0
Study 19968839 — intervention group
Group type: EXPERIMENTAL
Intervention: CSP test (immunochromatography)
Number of subjects: 0
Study 19968839 — intervention group
Group type: EXPERIMENTAL
Intervention: Chagatest v3.0 (ELISA)
Number of subjects: 0
Study 18198318 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance program delivered face-to-face
Number of subjects: 314
Study 18198318 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance program delivered via the Internet
Number of subjects: 314
Study 18198318 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 314
Study 15857208 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 10
Study 15857208 — intervention group
Group type: EXPERIMENTAL
Intervention: Melon juice
Number of subjects: 10
Study 15857208 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape juice
Number of subjects: 10
Study 15857208 — intervention group
Group type: EXPERIMENTAL
Intervention: Peach juice
Number of subjects: 10
Study 15857208 — intervention group
Group type: EXPERIMENTAL
Intervention: Plum juice
Number of subjects: 10
Study 15857208 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple juice
Number of subjects: 10
Study 15857208 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiwi juice
Number of subjects: 10
Study 15857208 — intervention group
Group type: EXPERIMENTAL
Intervention: Watermelon juice
Number of subjects: 10
Study 15857208 — intervention group
Group type: EXPERIMENTAL
Intervention: Pear juice
Number of subjects: 10
Study 12077585 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical corticosteroid (methylprednisolone aceponate)
Number of subjects: 45
Study 12077585 — intervention group
Group type: COMPARATOR
Intervention: Systemic antifungal (terbinafine)
Number of subjects: 45
Study 12077585 — intervention group
Group type: COMPARATOR
Intervention: Systemic antifungal (itraconazole)
Number of subjects: 45
Study 9579491 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 7
Study 9579491 — intervention group
Group type: COMPARATOR
Intervention: Control (no anesthesia)
Number of subjects: 7
Study 7650352 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation with guided imagery
Number of subjects: 60
Study 7650352 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 2668427 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (2 g every 24 h)
Number of subjects: 325
Study 2668427 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime (2 g every 6 h)
Number of subjects: 325
Study 327944 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular salbutamol 20 microgram/kg
Number of subjects: 36
Study 327944 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 36
Study 31769299 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation (group cognitive rehabilitation programme delivered in 10 weekly sessions)
Number of subjects: 449
Study 31769299 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 449
Study 31769299 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation
Number of subjects: 449
Study 30561849 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone and oral vitamin D (n=15)
Number of subjects: 30
Study 30561849 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone (n=15, control)
Number of subjects: 30
Study 30561849 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (n=30)
Number of subjects: 30
Study 28547999 — intervention group
Group type: COMPARATOR
Intervention: Handwriting intervention (self-managed at home, 1 hour, twice weekly for 6 months)
Number of subjects: 105